UM
CRL icon

UniSuper Management’s Charles River Laboratories CRL Stock Holding History

UniSuper Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$758K Sell
3,344
-5,581
-63% -$994K ﹤0.01% 536
2026
Q1 		$1.54M Buy
8,925
+293
+3% +$54.3K 0.01% 511
2025
Q4 		$1.72M Sell
8,632
-2,937
-25% -$533K 0.01% 495
2025
Q3 		$1.81M Buy
11,569
+595
+5% +$94.5K 0.01% 523
2025
Q2 		$1.67M Buy
10,974
+1,467
+15% +$196K 0.01% 523
2025
Q1 		$1.43M Sell
9,507
-526
-5% -$88.2K 0.01% 534
2024
Q4 		$1.85M Buy
10,033
+1,724
+21% +$332K 0.01% 477
2024
Q3 		$1.64M Buy
8,309
+1,203
+17% +$250K 0.01% 506
2024
Q2 		$1.47M Buy
7,106
+3,103
+78% +$703K 0.01% 500
2024
Q1 		$1.08M Buy
4,003
+3,278
+452% +$783K 0.01% 492
2023
Q4 		$171K Sell
725
-73
-9% -$14.4K ﹤0.01% 557
2023
Q3 		$156K Sell
798
-116
-13% -$23.8K ﹤0.01% 509
2023
Q2 		$192K Buy
+914
New +$182K ﹤0.01% 480

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

UniSuper Management's CRL Position: Q2 2026 in Review

UniSuper Management reduced its Charles River Laboratories (CRL) stake by 63% in Q2 2026, selling an estimated $994K and leaving 3,344 shares worth $758K. The position accounts for ﹤0.01% of the portfolio, ranked #536.

UniSuper Management first reported a position in CRL in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.85M in Q4 2024. 568 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • UniSuper Management held 3,344 shares of Charles River Laboratories worth $758K as of Q2 2026.
  • UniSuper Management sold 5,581 Charles River Laboratories shares in Q2 2026, an estimated $994K.
  • Charles River Laboratories made up ﹤0.01% of UniSuper Management's portfolio in Q2 2026, its #536 holding.
  • UniSuper Management first reported a position in Charles River Laboratories in Q2 2023 and has held it in 13 quarters since.
  • UniSuper Management's Charles River Laboratories position peaked at $1.85M in Q4 2024.
  • 568 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on UniSuper Management's 13F filing for Q2 2026, filed 14 Aug 2026.